Soleno Therapeutics Inc (SLNO)

May 15, 2025

Soleno Therapeutics Announces Presentations Featuring VYKAT(TM) XR in Prader-Willi Syndrome at PES 2025 - GlobeNewswire

May 15, 2025

May 15, 2025

New Clinical Data Shows VYKAT XR Improves Body Mass and Behavior in Prader-Willi Syndrome Patients - Stock Titan

May 15, 2025

May 13, 2025

Soleno Therapeutics Announces Presentations Featuring VYKAT(TM) XR in Prader-Willi Syndrome at ISPOR 2025 - GlobeNewswire

May 13, 2025

May 11, 2025

Is Soleno Therapeutics (SLNO) the Best Performing Healthcare Stock to Buy Now? - Insider Monkey

May 11, 2025

May 11, 2025

11 Best Performing Healthcare Stocks to Buy Now - Insider Monkey

May 11, 2025

May 09, 2025

Soleno Therapeutics, Inc. (NASDAQ:SLNO) Q1 2025 Earnings Call Transcript - Insider Monkey

May 09, 2025

May 08, 2025

Soleno Therapeutics Announces Oral Presentations Featuring - GlobeNewswire

May 08, 2025

May 08, 2025

Soleno Therapeutics Announces Oral Presentations Featuring VYKAT(TM) XR in Prader-Willi Syndrome at ESPE and ESE 2025 - Stock Titan

May 08, 2025

May 08, 2025

SLNO: Guggenheim Raises Price Target for Soleno Therapeutics | SLNO Stock News - GuruFocus

May 08, 2025

May 08, 2025

Guggenheim Boosts Price Target for Soleno Therapeutics (SLNO) | - GuruFocus

May 08, 2025

May 08, 2025

SLNO: Analyst Baird Maintains Outperform Rating, Raises Price Ta - GuruFocus

May 08, 2025

May 08, 2025

Oppenheimer maintains Soleno stock Outperform with $105 target - Investing.com

May 08, 2025

May 08, 2025

Soleno Therapeutics Reports Q1 2025 Results and VYKAT XR Launch - TipRanks

May 08, 2025

May 07, 2025

Earnings call transcript: Soleno Therapeutics misses Q1 2025 EPS forecast - Investing.com

May 07, 2025

May 07, 2025

Soleno Therapeutics Q1 2025 Earnings Call Transcript - MarketBeat

May 07, 2025

May 07, 2025

Earnings Flash (SLNO) Soleno Therapeutics Q1 Loss $0.95 Vs. FactSet Est. Loss $0.97 - marketscreener.com

May 07, 2025

May 07, 2025

Soleno Therapeutics shares rise on VYKAT XR launch update By Investing.com - Investing.com Nigeria

May 07, 2025

May 07, 2025

Soleno Therapeutics shares rise on VYKAT XR launch update - Investing.com Australia

May 07, 2025

May 07, 2025

SOLENO THERAPEUTICS Earnings Results: $SLNO Reports Quarterly Earnings - Nasdaq

May 07, 2025

May 07, 2025

Soleno Therapeutics Provides Update on U.S. Launch of VYKAT(TM) XR and Reports First Quarter 2025 Financial Results - The Manila Times

May 07, 2025

May 07, 2025

Soleno Therapeutics launches VYKAT XR for rare disease - Investing.com

May 07, 2025

May 07, 2025

Soleno Therapeutics Provides Update on U.S. Launch of - GlobeNewswire

May 07, 2025

May 06, 2025

Earnings call transcript: Soleno Therapeutics misses Q1 2025 EPS forecast By Investing.com - Investing.com UK

May 06, 2025

May 06, 2025

Soleno Therapeutics (SLNO) is on the Move, Here's Why the Trend Could be Sustainable - Yahoo Finance

May 06, 2025

May 06, 2025

Exploring High Growth Tech Stocks In The US Market - simplywall.st

May 06, 2025

May 05, 2025

Prader-Willi Syndrome Market to Reach New Heights in Growth - openPR.com

May 05, 2025

Apr 28, 2025

LogiCare3PL Supports Commercial Launch of Soleno Therapeutics' VYKAT XR Following FDA Approval - Longview News-Journal

Apr 28, 2025

Apr 26, 2025

Soleno Launches Pill For Hyperphagia In Prader-Willi Syndrome Patients But Retail’s Unmoved - MSN

Apr 26, 2025

Apr 24, 2025

Piper Sandler raises Soleno Therapeutics stock target to $145 By Investing.com - Investing.com Nigeria

Apr 24, 2025

Apr 24, 2025

Piper Sandler raises Soleno Therapeutics stock target to $145 - Investing.com

Apr 24, 2025

Apr 24, 2025

Soleno Therapeutics (SLNO) Price Target Boosted to $145 by Piper Sandler | SLNO Stock News - GuruFocus

Apr 24, 2025

Apr 23, 2025

Capnia Inc stock soars to 52-week high, hits $74.11 By Investing.com - Investing.com India

Apr 23, 2025

Apr 23, 2025

Capnia Inc stock soars to 52-week high, hits $74.11 - Investing.com Australia

Apr 23, 2025

Apr 23, 2025

Soleno Therapeutics to Report First Quarter 2025 Financial Results and Host Inaugural Quarterly Conference Call on May 7, 2025, at 4:30 PM ET - The Manila Times

Apr 23, 2025

Apr 23, 2025

Soleno Therapeutics to Report First Quarter 2025 Financial - GlobeNewswire

Apr 23, 2025

Apr 23, 2025

Soleno Therapeutics Launches First-Ever Earnings Call: Key Details for Q1 2025 Financial Results - Stock Titan

Apr 23, 2025

Apr 19, 2025

Soleno Therapeutics appoints CBIZ CPAs as new auditor By Investing.com - Investing.com India

Apr 19, 2025

Apr 19, 2025

How To Trade (SLNO) - news.stocktradersdaily.com

Apr 19, 2025

Apr 18, 2025

Soleno Therapeutics appoints CBIZ CPAs as new auditor - Investing.com Australia

Apr 18, 2025

Apr 18, 2025

Soleno Therapeutics, Inc. (NASDAQ:SLNO) Shares Acquired by Geode Capital Management LLC - Defense World

Apr 18, 2025

Apr 17, 2025

Franklin Resources Inc. Takes Position in Soleno Therapeutics, Inc. (NASDAQ:SLNO) - Defense World

Apr 17, 2025

Apr 14, 2025

Soleno launches Vykat xr for hyperphagia in Prader-Willi syndrome (SLNO:NASDAQ) - Seeking Alpha

Apr 14, 2025

Apr 14, 2025

Soleno Therapeutics launches FDA-approved PWS treatment By Investing.com - Investing.com South Africa

Apr 14, 2025

Apr 14, 2025

Soleno Therapeutics launches FDA-approved PWS treatment - Investing.com

Apr 14, 2025